Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 28, 2014 - Issue 9
635
Views
50
CrossRef citations to date
0
Altmetric
Articles

A new cyclopeptide with antifungal activity from the co-culture broth of two marine mangrove fungi

, , , &
Pages 616-621 | Received 26 Dec 2013, Accepted 21 Jan 2014, Published online: 26 Feb 2014
 

Abstract

A new cyclic tetrapeptide, cyclo-(l-leucyl-trans-4-hydroxy-l-prolyl-d-leucyl-trans-4-hydroxy-l-proline) (1), was isolated from the co-culture broth of two mangrove fungi Phomopsis sp. K38 and Alternaria sp. E33. The structure of 1 was determined by analysis of spectroscopic data and Marfey's analytic method. Primary bioassay demonstrated that compound 1 exhibited moderate to high inhibitory activity against four crop-threatening fungi including Gaeumannomyces graminis, Rhizoctonia cerealis, Helminthosporium sativum and Fusarium graminearum as compared with triadimefon.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (21102049), the Natural Science Foundation of Guangdong Province (9451064201003751), the Science and Technology Project of Guangzhou City (11C12100771), the Key Academic Program of the 3rd Phase ‘211 Project’ of South China Agricultural University (2009B010100001) and the national scholarship fund of China for studying abroad (for Dr Chunyuan Li, No. 201208440268).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.